Gunther Birznieks

All filings by Gunther Birznieks on record concern Vanda Pharmaceuticals Inc., in the capacity of senior executive. Between 2 January 2018 and 2 March 2026, the trades on record add up to 30 filings.

Sales make up the whole of the open-market record (19 sales, €1.8M). Other entries cover 10 share grants and 1 option exercise. 2026 to date brings no purchases and 1 sale.

The record was last updated on 4 March 2026 with an open-market sale (€298k) in Vanda Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.